Mylan repays $196 million loan early
This article was originally published in Scrip
Mylan has paid off early $196 million of bank loans last month that had been due in 2011. The generic drugs developer now has no term-loan obligations due until 2012. Mylan's CEO, Robert Coury, said the transaction reflected the company's strong operating cash flow and efforts to pay off its debt.